Mitochondrial DNA Depletion Syndrome 2 Myopathic Type

Clinical trial pipeline · Data from ClinicalTrials.gov

See which Mitochondrial DNA Depletion Syndrome 2 Myopathic Type trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

All recent trials (1 shown)

Active — Not RecruitingPhase 1/2

NCT03639701

Treatment of TK2 Deficiency With Thymidine and Deoxycytidine

Patients with confirmed mitochondrial DNA depletion syndrome 2 (thymidine kinase 2 \[TK2\] deficiency) have reduced levels of nucleotides (deoxythymidine monoph…

United States23 participantsStarted 2017-05-16

Treatment: Thymidine